Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Display Technologies for Generation of Ig Single Variable DomainsVladimir Bobkov, Bas van der Woning, Hans de Haard
Molecular and Cellular Endocrinology|January 29, 2019
Nanobodies: New avenues for imaging, stabilizing and modulating GPCRsTimo W M De Groof, Vladimir Bobkov, Raimond Heukers, et al.
Molecular Pharmacology|September 5, 2019
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3Vladimir Bobkov, Marta Arimont, Aurélien Zarca, et al.
Cells|March 25, 2022
Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?Anna Zakrzewicz, Celina Würth, Benedikt Beckert, et al.
Cells|May 28, 2022
Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942Anna Zakrzewicz, Celina Würth, Benedikt Beckert, et al.
Mabs|May 24, 2016
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loopsBas van der Woning, Gitte De Boeck, Christophe Blanchetot, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2020
Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonistsAli Işbilir, Jan Möller, Marta Arimont, et al.
Biochemical Pharmacology|August 4, 2024
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonismStephanie M Anbuhl, Xavier Dervillez, Saskia Neubacher, et al.
JCI Insight|May 7, 2024
Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albuminGuanglong Ma, Andrew R Crowley, Liesbeth Heyndrickx, et al.
Hemasphere|January 25, 2020
Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating SignalingTom Hofland, Sanne Endstra, Calum K P Gomes, et al.
Pageof 2